Teliso-V is an investigational antibody-drug conjugate (ADC) for patients with previously treated nonsquamous non-small cell lung cancer (NSCLC) with c-Met protein overexpression
Developed in consultation with clinicians and patients for an enhanced user experience
Enzalutamide Capsules will be produced at the Group’s manufacturing site at Moraiya, Ahmedabad
Global survey reveals top workforce concerns, evolving strategic priorities, and key technology investment areas for life sciences manufacturers
The sample seized by CDSCO is not manufactured by Torrent and is in fact non-genuine and spurious
Studies suggest that the protein Sclerostin plays a key role in the dysregulation of bone metabolism
Paliperidone extended-release tablets are an atypical antipsychotic agent indicated for treatment of schizophrenia
At 24 months, data from the Phase 1 exPDite trial continue to show a favorable safety profile in all 12 participants in the trial’s high and low dose cohorts
Pfizer's decision is based on the totality of clinical data
These clinical studies support the interchangeability of adalimumab-fkjp at low-concentration with high-concentration adalimumab and ustekinumab biosimilarity
Subscribe To Our Newsletter & Stay Updated
